Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CytomX Therapeutics (CTMX) Tax Rate (2016 - 2025)

CytomX Therapeutics' Tax Rate history spans 9 years, with the latest figure at 0.2% for Q4 2025.

  • For Q4 2025, Tax Rate fell 53.0% year-over-year to 0.2%; the TTM value through Dec 2025 reached 1.38%, down 208.0%, while the annual FY2025 figure was 1.39%, 209.0% down from the prior year.
  • Tax Rate reached 0.2% in Q4 2025 per CTMX's latest filing, up from 0.41% in the prior quarter.
  • In the past five years, Tax Rate ranged from a high of 56.09% in Q4 2023 to a low of 69.23% in Q2 2025.
  • Average Tax Rate over 3 years is 3.6%, with a median of 0.3% recorded in 2025.
  • The largest YoY upside for Tax Rate was -9bps in 2025 against a maximum downside of -6844bps in 2025.
  • A 3-year view of Tax Rate shows it stood at 56.09% in 2023, then tumbled by -99bps to 0.33% in 2024, then plummeted by -162bps to 0.2% in 2025.
  • Per Business Quant, the three most recent readings for CTMX's Tax Rate are 0.2% (Q4 2025), 0.41% (Q3 2025), and 69.23% (Q2 2025).